Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I3TD
|
||||
Former ID |
DIB016025
|
||||
Drug Name |
CRL-37212
|
||||
Synonyms |
Anaplastic lymphoma kinase inhibitors (cancer); CRL-37212; CRL-43425; CRL-82007; ALK inihibitors (cancer), ChemBridge Research; Anaplastic lymphoma kinase inhibitors (cancer), ChemBridge Research
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543509] | ||
Company |
ChemBridge Research Laboratories LLC
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(ccc2c1OCO2)c1c[nH]c(=O)c(c1)C(=O)Nc1ccc(cc1)CCN1CCN<br />(CC1)C
|
||||
Target and Pathway | |||||
Target(s) | ALK tyrosine kinase receptor | Target Info | Inhibitor | [543509] | |
KEGG Pathway | Non-small cell lung cancer | ||||
WikiPathways | Differentiation Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.